Although the results from different studies have varied, and primary endpoints not been met, it seems probable that treatment with 20 μg sc GAD-alum (Diamyd) twice at one-month intervals is efficacious in children and teenagers with recent-onset T1D. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.